Clinical significance of donor–recipient HLA matching on survival after myeloablative hematopoietic cell transplantation from unrelated donors
- 13 April 2007
- journal article
- Published by Wiley in Tissue Antigens
- Vol. 69 (s1) , 25-30
- https://doi.org/10.1111/j.1399-0039.2006.759_2.x
Abstract
The application of unrelated donor hematopoietic cell transplantation can be expanded with the use of mismatched donors if human leukocyte antigen (HLA) disparity does not lead to increased morbidity and mortality. The rules that govern permissibility of HLA mismatches are not well defined. The International Histocompatibility Working Group in hematopoietic cell transplantation measured the risks associated with locus-specific disparity in 4796 patients transplanted for low, intermediate, or high-risk hematologic diseases. The permissibility of a given HLA mismatch is in part defined by the locus and by disease risk.Keywords
This publication has 18 references indexed in Scilit:
- Clinical importance of HLA‐DPB1 in haematopoietic cell transplantationTissue Antigens, 2007
- Effect of HLA‐A2 allele disparity on clinical outcome in hematopoietic cell transplantation from unrelated donorsTissue Antigens, 2007
- HLA-DPB1 matching status has significant implications for recipients of unrelated donor stem cell transplantsBlood, 2006
- Limits of HLA mismatching in unrelated hematopoietic cell transplantationBlood, 2004
- Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcomeBlood, 2004
- Isolated HLA-C mismatches in unrelated donor transplantation for CMLBone Marrow Transplantation, 2004
- Roles of HLA-B, HLA-C and HLA-DPA1 incompatibilities in the outcome of unrelated stem-cell transplantationTissue Antigens, 2003
- DPB1 disparities contribute to severe GVHD and reduced patient survival after unrelated donor bone marrow transplantationBone Marrow Transplantation, 2002
- The clinical significance of human leukocyte antigen (HLA) allele compatibility in patients receiving a marrow transplant from serologically HLA-A, HLA-B, and HLA-DR matched unrelated donorsBlood, 2002
- The extent of HLA class II allele level disparity in unrelated bone marrow transplantation: analysis of 1259 National Marrow Donor Program donor–recipient pairsBone Marrow Transplantation, 2000